+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Anemia Drugs - Global Strategic Business Report - Product Thumbnail Image

Anemia Drugs - Global Strategic Business Report

  • Report
  • March 2026
  • 383 Pages
  • Global
From
From
From
From
From
Tuberculosis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Tuberculosis Therapeutics - Global Strategic Business Report

  • Report
  • March 2026
  • 283 Pages
  • Global
From
Acute Coronary Syndrome - Global Strategic Business Report - Product Thumbnail Image

Acute Coronary Syndrome - Global Strategic Business Report

  • Report
  • March 2026
  • 158 Pages
  • Global
From
From
From
From
From
From
Endometriosis Drugs - Global Strategic Business Report - Product Thumbnail Image

Endometriosis Drugs - Global Strategic Business Report

  • Report
  • March 2026
  • 191 Pages
  • Global
From
From
From
From
Sepsis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Sepsis Therapeutics - Global Strategic Business Report

  • Report
  • March 2026
  • 291 Pages
  • Global
From
From
From
Narcolepsy Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Narcolepsy Therapeutics - Global Strategic Business Report

  • Report
  • March 2026
  • 363 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more